欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0498/003
药品名称Aprepitant Sandoz
活性成分
    • Aprepitant 80.0 mg
    • Aprepitant 125.0 mg
剂型Capsule, hard
上市许可持有人Sandoz Hungária Kft. Bartók Béla út 43-47 1114 Budapest
参考成员国 - 产品名称Hungary (HU)
APREPITANT SANDOZ 125 mg kemény kapszula + APREPITANT SANDOZ 80 mg kemény kapszula
互认成员国 - 产品名称
    • Slovakia (SK)
    • Croatia (HR)
    • Germany (DE)
      Aprepitant HEXAL 120mg plus 80mg, Hartkapseln
    • Denmark (DK)
    • Belgium (BE)
      Aprepitant Sandoz 125 mg + 80 mg, harde capsules
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Aprepitant Sandoz 80 mg + 125 mg – Hartkapseln
    • France (FR)
    • Italy (IT)
    • Poland (PL)
      Aprepitant Sandoz
    • Latvia (LV)
      Aprepitant Sandoz 125 mg cietās kapsulas + Aprepitant Sandoz 80 mg cietās kapsulas
    • Lithuania (LT)
      Aprepitant Sandoz 125 mg kietoji kapsulė Aprepitant Sandoz 80 mg kietosios kapsulės
    • Estonia (EE)
      Aprepitant Sandoz
    • Bulgaria (BG)
      Aprepitant Sandoz
    • Czechia (CZ)
      Aprepitant Sandoz
    • Spain (ES)
许可日期2017/12/04
最近更新日期2024/11/15
药物ATC编码
    • A04AD12 aprepitant
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase